UBS Raises Surgery Partners Price Target to $23.50 From $21.00
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Bristol-Myers Squibb Reports Quarterly Results
The company reported results for the quarter ended September 30; no figures were provided.
M impact | EQUITY | Oct 29, 2026, 02:16 PM UTC
Shelter Pharma Gets Export Orders Worth 34.7 Million Rupees
M impact | EQUITY | Oct 29, 2026, 02:16 PM UTC
Phinia Q3 Adjusted Earnings and Revenue Rise; Shares Advance
Phinia reported higher Q3 adjusted earnings and revenue, while its shares advanced.
M impact | EQUITY | Oct 29, 2026, 02:14 PM UTC
South Electronics Reports Q3 Net Loss of 137,471 Dinars
M impact | EQUITY | Oct 29, 2026, 02:13 PM UTC
Trinity Industries Reports Lower Q3 Earnings, Higher Revenue; Maintains 2026 EPS Outlook
M impact | EQUITY | Oct 29, 2026, 02:13 PM UTC
Jinko Power Q3 Net Profit Falls 95.96% Year Over Year
M impact | EQUITY | Oct 29, 2026, 02:11 PM UTC